As shown in Fig. 2, according to the KEGG reference pathways, indicators with significantly discriminative power were the “ABC transporters”, “Glycerophospholipid metabolism”, “Choline metabolism in cancer”, “Primary bile acid biosynthesis”, and “Biosynthesis of unsaturated fatty acid”, which showed significant enrichment with HFD treatment. The gene discussed is ABCG2; the disease is cancer.